153 related articles for article (PubMed ID: 38811532)
1. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis.
Sajiir H; Keshvari S; Wong KY; Borg DJ; Steyn FJ; Fercher C; Taylor K; Taylor B; Barnard RT; Müller A; Moniruzzaman M; Miller G; Wang R; Fotheringham A; Schreiber V; Sheng YH; Hancock JL; Loo D; Burr L; Huynh T; Lockett J; Ramm GA; Macdonald GA; Prins JB; McGuckin MA; Hasnain SZ
Nat Commun; 2024 May; 15(1):4528. PubMed ID: 38811532
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis.
Sajiir H; Wong KY; Müller A; Keshvari S; Burr L; Aiello E; Mezza T; Giaccari A; Sebastiani G; Dotta F; Ramm GA; Macdonald GA; McGuckin MA; Prins JB; Hasnain SZ
Nat Commun; 2024 May; 15(1):4527. PubMed ID: 38811550
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.
Wang X; Ota N; Manzanillo P; Kates L; Zavala-Solorio J; Eidenschenk C; Zhang J; Lesch J; Lee WP; Ross J; Diehl L; van Bruggen N; Kolumam G; Ouyang W
Nature; 2014 Oct; 514(7521):237-41. PubMed ID: 25119041
[TBL] [Abstract][Full Text] [Related]
4. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion.
Zhu L; Litts B; Wang Y; Rein JA; Atzrodt CL; Chinnarasu S; An J; Thorson AS; Xu Y; Stafford JM
Mol Metab; 2024 May; 83():101932. PubMed ID: 38589002
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
Diabetes Obes Metab; 2016 Feb; 18(2):142-51. PubMed ID: 26462866
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis.
Xue J; Nguyen DT; Habtezion A
Gastroenterology; 2012 Dec; 143(6):1670-80. PubMed ID: 23022954
[TBL] [Abstract][Full Text] [Related]
7. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module.
Bendixen SM; Jakobsgaard PR; Hansen D; Hejn KH; Terkelsen MK; Bjerre FA; Thulesen AP; Eriksen NG; Hallenborg P; Geng Y; Dam TV; Larsen FT; Wernberg CW; Vijayathurai J; Scott EAH; Marcher AB; Detlefsen S; Grøntved L; Dimke H; Berdeaux R; de Aguiar Vallim TQ; Olinga P; Lauridsen MM; Krag A; Blagoev B; Ravnskjaer K
J Hepatol; 2024 Mar; 80(3):467-481. PubMed ID: 37972658
[TBL] [Abstract][Full Text] [Related]
8. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.
Fabbrini E; Cella M; McCartney SA; Fuchs A; Abumrad NA; Pietka TA; Chen Z; Finck BN; Han DH; Magkos F; Conte C; Bradley D; Fraterrigo G; Eagon JC; Patterson BW; Colonna M; Klein S
Gastroenterology; 2013 Aug; 145(2):366-74.e1-3. PubMed ID: 23597726
[TBL] [Abstract][Full Text] [Related]
9. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion.
Gerst F; Wagner R; Kaiser G; Panse M; Heni M; Machann J; Bongers MN; Sartorius T; Sipos B; Fend F; Thiel C; Nadalin S; Königsrainer A; Stefan N; Fritsche A; Häring HU; Ullrich S; Siegel-Axel D
Diabetologia; 2017 Nov; 60(11):2240-2251. PubMed ID: 28791439
[TBL] [Abstract][Full Text] [Related]
10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA
Xie Y; Huang Y; Li ZY; Jiang W; Shi NX; Lu Y; Cao G; Yin Z; Lin XJ
Mol Cancer; 2024 May; 23(1):95. PubMed ID: 38720319
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice.
Qiao YY; Liu XQ; Xu CQ; Zhang Z; Xu HW
World J Gastroenterol; 2016 Jun; 22(21):5023-32. PubMed ID: 27275094
[TBL] [Abstract][Full Text] [Related]
13. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity.
Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
[TBL] [Abstract][Full Text] [Related]
15. Gadofullerene Nanoparticles Reverse Dysfunctions of Pancreas and Improve Hepatic Insulin Resistance for Type 2 Diabetes Mellitus Treatment.
Li X; Zhen M; Zhou C; Deng R; Yu T; Wu Y; Shu C; Wang C; Bai C
ACS Nano; 2019 Aug; 13(8):8597-8608. PubMed ID: 31314991
[TBL] [Abstract][Full Text] [Related]
16. Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats.
Tian YF; He CT; Chen YT; Hsieh PS
World J Gastroenterol; 2013 May; 19(18):2761-71. PubMed ID: 23687413
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL
Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590
[TBL] [Abstract][Full Text] [Related]
18. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice.
Lu Z; Li Y; Syn WK; Li AJ; Ritter WS; Wank SA; Lopes-Virella MF; Huang Y
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E30-E42. PubMed ID: 33103454
[TBL] [Abstract][Full Text] [Related]
19. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
Yu Y; Chen D; Zhao Y; Zhu J; Dong X
Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
[TBL] [Abstract][Full Text] [Related]
20. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
